Lucd, provider of the most trusted and collaborative AI platform enabling organizations to build production-ready AI solutions, today announced its sophisticated predictive disease spreading model, Avicenna, now includes more than three billion people worldwide, nearly one-third of the global population. Additionally, the model has maintained 94 percent accuracy during this growth in predicting the spread of the COVID-19 virus 90 days out. Free to the public, Avicenna is a global pandemic model of infectious disease spread which unmasks the unknowns of COVID-19.
“We don’t deliver simple projections which are based on historical or incomplete information. With Avicenna, we deliver actual AI-led predictions with an unprecedented understanding of where the disease is today, and where it will be in the future with a high degree of accuracy. For 13 years we have been at the forefront of advising major organizations where viruses will hit and to the extent they should expect their workforces to be impacted. During COVID-19 we predicted the 45 day spread in cities such as New York and Dallas with 95 percent accuracy. Armed with this data, leaders are able to mitigate spread and better understand and prepare for the downstream impact,” said John Leschorn, COO, Lucd.
In 2006, Lucd began development on a unique capability for global pandemic modeling in response to the Avian influenza outbreak (H5N1). Working in collaboration with the U.S. Center for Disease Control and Prevention, MIT and Rensselaer Polytechnic Institute, the company developed the world’s largest-scale capability for modeling infectious disease spread at the person-level. Expanding on that baseline software, Avicenna was launched in July 2020 to help organizations prepare better for and mitigate the impact of the current pandemic.
“With the onset of the coronavirus epidemic we immediately began to work with the Joint AI Center in the U.S. Department of Defense, Health and Human Services, Defense Threat Agency and the U.S. National Guard to provide insights that would have a definitive effect on planning nationwide. Avicenna is built to predict not just disease spread but its impact on commerce and infrastructure. Furthermore, the power of Avicenna is understanding the impact of infectious disease at the most granular level possible. Avicenna results are typically aggregated at the neighborhood, or Census Tract level in the United States. For our enterprise customers, we are able to provide information on their workplace locations, and their workforce community down to the individual,” said Leschorn.
Lucd plans to continually expand the Avicenna platform to include new data sets and new population data to further increase the integrity of results in the short-term and to be able to look at the long-haul effects of COVID-19 in years to come. These insights are expected to have an impact on a variety of industries, including manufacturing, healthcare, pharmaceutical and insurance.
For more information visit https://www.avicenna.lucd.ai/.
Lucd, was named a Cool Vendors in Enterprise AI Governance and Ethical Response 2019. By unleashing the power of data, the Lucd Enterprise end to end AI platform allows all organizations to conduct machine learning in a responsible way. Lucd builds competitive digital advantage through leveraging data assets; Digital ROI; and providing the ability to exploit market knowledge. Lucd develops pioneering capabilities in AI, Big Data, Data Fusion and Machine Learning. Visit Lucd online at: https://www.lucd.ai/.